Biochips (Microarrays/Microfluidics) Global Market – Forecast To 2023

Published by IQ4I on 22nd June 2017 | Ref: 1005258 | This Report Is In Stock

$4950 | Single User
$6750 | Site License
$9000 | Enterprise License
$4950 | Single User
$6750 | Site License
$9000 | Enterprise License

Introduction

Biochips come handy as thousands of experiments are performed on a small chip with a solid platform and acts like a mini laboratory. Usage of biochips has increased in the past decade as its application varies from high throughput screening in drug discovery to personalized medicine.

The global biochips market is expected to grow at double digit CAGR to reach ,851.1 million by 2023. Biochips market is mainly classified into technologies, products, application and end-users. The global biochips market is broadly classified as micro arrays and microfluidics based on technology. Based on products, the market is classified into Instruments, Reagents & Consumables and Software & Services. Biochips market is segmented on the basis of application as Genomics, Proteomics, Drug discovery, Diagnostics, Food & agricultural testing and others. Genomics application segment is further classified into SNP Genotyping, Gene Expression and Others where as Drug discovery segment is further sub segmented into Target Identification & Validation, HTS (High Throughput screening) and Lead Optimization. Diagnostics segment is further divided into Cancer diagnostics and other diagnostics. End-Users are further classified into Pharmaceutical & Biotech companies, Academic & Research laboratories, Diagnostic laboratories, CROs (Contract and Research Organizations) and others.

Among microarrays and Microfluidics, Microfluidics occupies the major share in 2016 and is expected to grow at a highest CAGR from 2016 to 2023. Among products Reagents & consumables occupy the major share of XX% in 2016 and are expected to grow at a CAGR of XX% from 2016 to 2023 to reach $XX million by 2023. Among Application segment Diagnostics commanded the larger revenue in 2016 and is expected to grow at a highest CAGR of XX% from 2016 to 2023. Among Genomics, SNP genotyping occupies a major share in 2016 with a CAGR of XX% from 2016 to 2023. Target Identification & Validation in Drug discovery segment occupies a major share of XX% in 2016 and similarly other diagnostics occupies a major share of XX% in 2016 and grows with a CAGR of XX% from 2016 to 2023. Diagnostic laboratories occupy a major share of XX% in 2016 and grow with a maximum CAGR of XX% from 2016 to 2023.

Revolution in the field of genomics, proteomics as well as rapid drug discovery increased the demand for biochips. In addition, increase in diagnosis and treatment of cancer and genetic diseases, approval for personalized medicines and invention of novel technologies in biochips drives the market of biochips. Standardization and quality assurance of biochips, technological ease in handling the biochips especially in the areas of diagnosis and treatment, high cost along with ethical and social issues hinders the market growth.

Lifestyle changes owing to increase in cancer, diabetes and hypertension patients, early diagnosis and treatment of diseases, advancement of biochips with its wide application areas shows that biochip market has vast opportunities in the coming years.

North America accounts for the highest market share in 2016 and followed by Europe. Steep rise in genetic diagnosis, huge corporate outsourcing for drug discovery, increase in personalized medicines and favourable government policies makes U.S. the leader of Biochips market. However, Asian countries especially China and Japan are the fastest growing regions with its growing demand for biochips and increasing research investments. Asia-Pacific grows with a highest CAGR of XX% from 2016 to 2023.

Major players in biochips market include Abbott laboratories (U.S.), Agilent Technologies (U.S.), Becton-Dickinson Company (U.S.), Bio-Rad Laboratories (U.S.), Danaher Corporation (U.S.), Fluidigm Corporation (U.S.), GE Healthcare (U.S.), Illumina (U.S.), PerkinElmer, Inc. (U.S.) and Thermo Fisher Scientific, Inc. (U.S.).

The report provides an in depth market analysis of the above mentioned segments across the following regions:

• North America

• Europe

• Asia-Pacific

• Rest of the World

Table of Contents

1 EXECUTIVE SUMMARY 29

2 INTRODUCTION 38

2.1 KEY TAKE AWAYS 38

2.2 REPORT DESCRIPTION 39

2.3 MARKETS COVERED 41

2.4 STAKEHOLDERS 43

2.5 RESEARCH METHODOLOGY 44

3 MARKET ANALYSIS 53

3.1 INTRODUCTION 53

3.2 MARKET SEGMENTATION 54

3.3 FACTORS INFLUENCING MARKET 56

3.4 PORTER’S FIVE FORCE ANALYSIS 63

3.5 REGULATORY GUIDELINES 67

3.6 MARKET SHARE ANALYSIS BY MAJOR PLAYERS 71

MAJOR PLAYERS 73

BY MAJOR PLAYERS 75

3.7 PATENT TRENDS 77

3.8 SUPPLY CHAIN ANALYSIS 79

3.9 BIOCHIPS UNDER CLINICAL TRIAL 81

3.10 NEW PRODUCT LAUNCHES 83

3.11 TECHNOLOGICAL ADVANCEMENTS 89

CANCER CELLS 91

4 BIOCHIPS GLOBAL MARKET, BY TECHNOLOGY 93

4.1 INTRODUCTION 93

4.2 MICROARRAYS 95

4.3 LAB-ON-A-CHIP (MICROFLUIDICS) 116

5 BIOCHIPS GLOBAL MARKET, BY PRODUCTS 138

5.1 INTRODUCTION 138

5.2 INSTRUMENTS 141

5.3 REAGENTS AND CONSUMABLES 143

5.4 SOFTWARE AND SERVICES 145

6 BIOCHIPS GLOBAL MARKET, BY APPLICATIONS 149

6.1 INTRODUCTION 149

6.2 GENOMICS 152

6.3 PROTEOMICS 161

6.4 DRUG DISCOVERY & DEVELOPMENT 164

6.5 DIAGNOSTICS 174

6.6 FOOD AND AGRICULTURE TESTING 180

6.7 OTHERS 182

7 BIOCHIPS GLOBAL MARKET, BY END-USERS 186

7.1 INTRODUCTION 186

7.2 PHARMACEUTICAL AND BIOTECH COMPANIES 189

7.3 ACADEMIC & RESEARCH LABORATORIES 191

7.4 CONTRACT RESEARCH ORGANISATIONS 193

7.5 DIAGNOSTIC LABORATORIES 195

7.6 OTHERS 196

8 REGIONAL MARKET ANALYSIS 198

8.1 INTRODUCTION 198

8.2 NORTH AMERICA 200

8.3 EUROPE 221

8.4 ASIA-PACIFIC 245

8.5 REST OF THE WORLD 272

9 COMPETITIVE LANDSCAPE 293

9.1 INTRODUCTION 293

9.2 NEW PRODUCT LAUNCHES 294

9.3 AGREEMENTS, PARTNERSHIP, COLLABORATION & JOINT VENTURES 299

9.4 APPROVALS 302

9.5 MERGERS & ACQUISITIONS 307

9.6 OTHER DEVELOPMENTS 309

10 MAJOR COMPANIES 310

10.1 ABBOTT LABORATORIES 310

10.2 AGILENT TECHNOLOGIES, INC. 318

10.3 BECTON DICKINSON AND COMPANY 329

10.4 BIO-RAD LABORATORIES 337

10.5 DANAHER CORPORATION 346

10.6 FLUIDIGM CORPORATION 359

10.7 GE HEALTHCARE 371

10.8 ILLUMINA, INC. 378

10.9 PERKINELMER, INC. 385

10.10 THERMOFISHER SCIENTIFIC INC. 393

Additional Details

Publisher

IQ4I

Publisher Information

Reference

1005258 |

Number of Pages

404

Report Format

PDF

Related Reports

Title
Date Published
Price From
Link

Published by S&P Consulting
15-03-2017

$2,800 USD

Published by S&P Consulting
15-03-2017

$3,800 USD

Published by S&P Consulting
15-03-2017

$3,100 USD

Published by S&P Consulting
15-03-2017

$3,800 USD

This report is published by IQ4I

Download Free Report Summary PDF

Biochips (Microarrays/Microfluidics) Global Market  – Forecast To 2023 | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.